p73 in apoptosis

[1]  W. Kaelin,et al.  Role of the newer p53 family proteins in malignancy , 2001, Apoptosis.

[2]  U. Moll,et al.  Oncogenes Induce and Activate Endogenous p73 Protein* , 2001, The Journal of Biological Chemistry.

[3]  R. Iggo,et al.  Inactivate the remaining p53 allele or the alternate p73? Preferential selection of the Arg72 polymorphism in cancers with recessive p53 mutants but not transdominant mutants. , 2001, Carcinogenesis.

[4]  C. Prives,et al.  A Subset of Tumor-Derived Mutant Forms of p53 Down-Regulate p63 and p73 through a Direct Interaction with the p53 Core Domain , 2001, Molecular and Cellular Biology.

[5]  Xinbin Chen,et al.  p73 is transcriptionally regulated by DNA damage, p53, and p73 , 2001, Oncogene.

[6]  F. Vikhanskaya,et al.  p73α Overexpression Is Associated with Resistance to Treatment with DNA-damaging Agents in a Human Ovarian Cancer Cell Line , 2001 .

[7]  M. Gatei,et al.  Transactivation-deficient p73α (p73Δexon2) inhibits apoptosis and competes with p53 , 2001, Oncogene.

[8]  X. Zeng,et al.  p300 Does Not Require Its Acetylase Activity to Stimulate p73 Function* , 2001, The Journal of Biological Chemistry.

[9]  上田 佳秀.  New p73 variants with altered C-terminal structures have varied transcriptional activities , 2001 .

[10]  M. Gatei,et al.  Transactivation-deficient p73alpha (p73Deltaexon2) inhibits apoptosis and competes with p53. , 2001, Oncogene.

[11]  F. Vikhanskaya,et al.  P73a overexpression is associated with resistance to treatment with DNA-damaging agents in a human ovarian cancer cell line. , 2001, Cancer research.

[12]  B. Gusterson,et al.  Preferential retention of codon 72 arginine p53 in squamous cell carcinomas of the vulva occurs in cancers positive and negative for human papillomavirus. , 2000, Cancer research.

[13]  B. Pützer,et al.  Role of the p53-homologue p73 in E2F1-induced apoptosis , 2000, Nature Genetics.

[14]  A. Yang,et al.  p63 and p73: p53 mimics, menaces and more , 2000, Nature Reviews Molecular Cell Biology.

[15]  K. Vousden,et al.  Minireviewp 53 : Death Star able to induce the defensive p 53 response to oncogene , 2000 .

[16]  G. Melino,et al.  Enhanced p73 expression during differentiation and complex p73 isoforms in myeloid leukemia. , 2000, Biochemical and biophysical research communications.

[17]  W. Kaelin,et al.  A common E2F-1 and p73 pathway mediates cell death induced by TCR activation , 2000, Nature.

[18]  David I. Smith,et al.  Role for the p53 homologue p73 in E2F-1-induced apoptosis , 2000, Nature.

[19]  M. Tschan,et al.  Differential expression of p73 splice variants and protein in benign and malignant ovarian tumours , 2000, International journal of cancer.

[20]  A. Levine,et al.  Physical and Functional Interaction between p53 Mutants and Different Isoforms of p73* , 2000, The Journal of Biological Chemistry.

[21]  F. McKeon,et al.  An anti-apoptotic role for the p53 family member, p73, during developmental neuron death. , 2000, Science.

[22]  R. Bernards,et al.  Distinct Initiation and Maintenance Mechanisms Cooperate to Induce G1 Cell Cycle Arrest in Response to DNA Damage , 2000, Cell.

[23]  B. Gusterson,et al.  A common polymorphism acts as an intragenic modifier of mutant p53 behaviour , 2000, Nature Genetics.

[24]  R. Berkowitz,et al.  Analysis of p73 in human borderline and invasive ovarian tumor , 2000, Oncogene.

[25]  A. Yang,et al.  p73-deficient mice have neurological, pheromonal and inflammatory defects but lack spontaneous tumours , 2000, Nature.

[26]  Hua Lu,et al.  The N-Terminal Domain of p73 Interacts with the CH1 Domain of p300/CREB Binding Protein and Mediates Transcriptional Activation and Apoptosis , 2000, Molecular and Cellular Biology.

[27]  T. Tokino,et al.  Adenovirus‐mediated Transfer of p53‐related Genes Induces Apoptosis of Human Cancer Cells , 2000, Japanese journal of cancer research : Gann.

[28]  Y. Shaul.  c-Abl: activation and nuclear targets , 2000, Cell Death and Differentiation.

[29]  G. Melino,et al.  Structure, function and regulation of p63 and p73 , 1999, Cell Death and Differentiation.

[30]  X. Chen,et al.  The p53 family: same response, different signals? , 1999, Molecular medicine today.

[31]  K. Helin,et al.  CDC25A Phosphatase Is a Target of E2F and Is Required for Efficient E2F-Induced S Phase , 1999, Molecular and Cellular Biology.

[32]  N. L. Thangue,et al.  Promoter specificity and stability control of the p53-related protein p73 , 1999, Oncogene.

[33]  K. Engeland,et al.  Expression of p73 and its relation to histopathology and prognosis in hepatocellular carcinoma. , 1999, Journal of the National Cancer Institute.

[34]  U. Moll,et al.  Overexpression of the wild type p73 gene in breast cancer tissues and cell lines. , 1999, Cancer research.

[35]  Jijie Gu,et al.  p73 is regulated by tyrosine kinase c-Abl in the apoptotic response to DNA damage , 1999, Nature.

[36]  Antonio Costanzo,et al.  The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage , 1999, Nature.

[37]  A. Jochemsen,et al.  Distinct Regulation of p53 and p73 Activity by Adenovirus E1A, E1B, and E4orf6 Proteins , 1999, Molecular and Cellular Biology.

[38]  C. L. Cunsolo,et al.  Different p73 splicing variants are expressed in distinct tumour areas of a multifocal neuroblastoma , 1999, Cell Death and Differentiation.

[39]  G Melino,et al.  Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants ε and ζ , 1999, Cell Death and Differentiation.

[40]  A. Look,et al.  Lack of homozygously inactivated p73 in single-copy MYCN primary neuroblastomas and neuroblastoma cell lines. , 1999, Neoplasia.

[41]  C. Prives,et al.  p73 Function Is Inhibited by Tumor-Derived p53 Mutants in Mammalian Cells , 1999, Molecular and Cellular Biology.

[42]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[43]  G Melino,et al.  Additional complexity in p73: induction by mitogens in lymphoid cells and identification of two new splicing variants epsilon and zeta. , 1999, Cell death and differentiation.

[44]  V. Rotter,et al.  Introduction: p53 – the first twenty years , 1999, Cellular and Molecular Life Sciences CMLS.

[45]  Xinbin Chen,et al.  The potential tumor suppressor p73 differentially regulates cellular p53 target genes. , 1998, Cancer research.

[46]  G. Melino,et al.  Two New p73 Splice Variants, γ and δ, with Different Transcriptional Activity , 1998, Journal of Experimental Medicine.

[47]  W. Kaelin,et al.  Viral Oncoproteins Discriminate between p53 and the p53 Homolog p73 , 1998, Molecular and Cellular Biology.

[48]  C. Sherr,et al.  Tumor surveillance via the ARF-p53 pathway. , 1998, Genes & development.

[49]  Karen H. Vousden,et al.  p14ARF links the tumour suppressors RB and p53 , 1998, Nature.

[50]  M. Serrano,et al.  p19ARF links the tumour suppressor p53 to Ras , 1998, Nature.

[51]  A. Yang,et al.  p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. , 1998, Molecular cell.

[52]  J L Cleveland,et al.  Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.

[53]  S. Lowe,et al.  E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.

[54]  J. Jen,et al.  A new human p53 homologue , 1998, Nature Medicine.

[55]  Chikashi Ishioka,et al.  Cloning and functional analysis of human p51, which structurally and functionally resembles p53 , 1998, Nature Medicine.

[56]  W. El-Deiry,et al.  Regulation of p53 downstream genes. , 1998, Seminars in cancer biology.

[57]  K. Hunt,et al.  P53 Carcinoma Cell Lines and Does Not Require Factor E2f-1 Induces Apoptosis in Human Breast and Ovarian Adenovirus-mediated Overexpression of the Transcription Updated Version Citing Articles E-mail Alerts Adenovirus-mediated Overexpression of the Transcription Factor E2f-1 Induces Apoptosis in Hum , 2013 .

[58]  W. Kaelin,et al.  p73 is a human p53-related protein that can induce apoptosis , 1997, Nature.

[59]  Wei Gu,et al.  Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain , 1997, Cell.

[60]  A. Yang,et al.  Monoallelically Expressed Gene Related to p53 at 1p36, a Region Frequently Deleted in Neuroblastoma and Other Human Cancers , 1997, Cell.

[61]  Xin Lu,et al.  E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. , 1997, Genes & development.

[62]  K. Helin,et al.  Induction of DNA synthesis and apoptosis are separable functions of E2F-1. , 1997, Genes & development.

[63]  K. Gardner,et al.  Recruitment of p300/CBP in p53-Dependent Signal Pathways , 1997, Cell.

[64]  D. Livingston,et al.  Binding and modulation of p53 by p300/CBP coactivators , 1997, Nature.

[65]  D. Baltimore,et al.  Ataxia telangiectasia mutant protein activates c-Abl tyrosine kinase in response to ionizing radiation , 1997, Nature.

[66]  J. Cleveland,et al.  E2F-1 cooperates with topoisomerase II inhibition and DNA damage to selectively augment p53-independent apoptosis , 1997, Molecular and cellular biology.

[67]  W. Kaelin,et al.  p73 is a simian [correction of human] p53-related protein that can induce apoptosis. , 1997, Nature.

[68]  Thierry Soussi,et al.  Somatic point mutations in the p53 gene of human tumors and cell lines: updated compilation , 1996, Nucleic Acids Res..

[69]  W. Kaelin,et al.  Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[70]  A. Levine,et al.  p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[71]  B. Vogelstein,et al.  p53 mutations in human cancers. , 1991, Science.